State Ledger
Company profile

Curanex Pharmaceuticals Inc CIK 2025942

Ticker
CURX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Jericho, NY 11753
Fiscal year end
2025 (FY)
Market Data
Close
$5.20
Change
+$0.43
Change %
9.01%
Volume
1,549

CURX · trading date Oct 9, 2026 · previous close $4.77 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$4.23M
Total assets
$11.58M
Total liabilities
$361.0K
Stockholders' equity
$11.22M
Cash & equivalents
$5.00M
Operating income
-$4.24M
Operating cash flow
-$10.48M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
3.1%
Equity / assets
96.9%
CapEx / revenue
—
Operating cash flow / net income
2.48×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$4.23M $11.58M $361.0K $11.22M
2024 — -$361.5K $517.9K $14.6K $503.4K
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-04
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Jericho, NY 11753
2 JERICHO PLAZA,
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:46 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies